β-Cell maturation leads to in vitro sensitivity to cytotoxins

Diabetes

Volumn 48, Issue 12, 1999, Pages 2324-2332

  Nielsen, Karin ^a   Karlsen, Allan E ^a   Deckert, Marja ^a   Madsen, Ole D ^b   Serup, Palle ^b   Mandrup Poulsen, Thomas ^a   Nerup, Jørn ^a  

^a STENO DIABETES CENTER   (Denmark)

^b HAGEDORN RESEARCH INSTITUTE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIN;

APOPTOSIS; ARTICLE; CELL FREE SYSTEM; CELL MATURATION; CYTOKINE RELEASE; DNA DAMAGE; GENETIC TRANSFECTION; HOMEOBOX; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATORY CELL; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LANGERHANS CELL; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 0033511648     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.12.2324     Document Type: Article

References (57)

1. Gepts W: Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 14:619-633, 1965
2. Mandrup-Poulsen T: The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005-1029, 1996
3. Nerup J, Mandrup-Poulsen T, Helquist S, Andersen HU, Pociot F, Reimers JI, Cuartero BG, Karlsen AE, Bjerre U, Lorenzen T: On the pathogenesis of IDDM. Diabetologia 37:82-89, 1994
4. Eizirik DL, Flodström M, Karlsen AE, Welsh N: The harmony of the spheres: inducible nitric oxide synthase and related genes in pancreatic beta cells. Diabetologia 39:875-890, 1996
5. Fehsel K, Jalowy A, Qi S, Burkait V, Hartmann B, Kolb H: Islet cell DNA is a target of inflammatory attack by nitric oxide. Diabetes 42:496-500, 1993
6. Delaney CA, Pavlovic D, Hoorens A, Pipeleers DG, Eizirik DL: Cytokines induce deoxyribonucleic acid strand breaks and apoptosis in human pancreatic islet cells. Endocrinology 138:2610-2614, 1997
7. Corbett JA, Lancaster JR Jr, Sweetland MA, McDaniel ML: Interleukin-1-β-induced formation of EPR-detectable iron-nitrosyl complexes in islets of Langerhans. J Biol Chem 266:21351-21354, 1991
8. Welsh N, Eizirik DL, Bendtzen K, Sandler S: Interleukin-1β-induced nitric oxide production in isolated rat pancreatic islets requires gene transcription and may lead to inhibition of the Krebs cycle enzyme aconitase. Endocrinology 129:3167-3173, 1991
9. Hasan K, Heesen BJ, Corbel JA, McDaniel ML, Chang K, Allison W, Wolffenbuttel BHR, Williamson JR, Tilton RG: Inhibition of nitric oxide formation by guanidines. Eur J Pharmacol 249:101-106, 1993
10. Southern C, Schulster D, Green IC: Inhibition of insulin secretion by interleukin-1-β and tumor necrosis factor-α via an L-arginine-dependent nitric oxide generating mechanism. FEBS Lett 276:42-44, 1990
11. Andersen HU, Jørgensen KH, Egeberg J, Mandrup-Poulsen T, Nerup J: Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans. Diabetes 43:770-777, 1994
12. Wilson GL, Leiter EH: Streptozotocin interactions with pancreatic β-cells and the induction of insulin-dependent diabetes. Curr Top Microbiol 156:27-54, 1990
13. Turk J, Corbett JA, Ramanadham S, Bohrer A, McDaniel M: Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem Biophys Res Comm 1973:1458-1464, 1993
14. Tanaka Y, Shimizu H, Sato M, Mon I, Shimomura V: Involvement of spontaneous nitric oxide production in the diabetogenic action of streptozotocin. Pharmacology 50:69-73, 1995
15. Schnedl WJ, Ferber S, Johnson JH, Newgard CB: STZ transport and cytotoxicity. Specific enhancement in GLUT-2-expressing cells. Diabetes 43:1326-1333, 1994
16. Alpert S, Hanahan D, Teitelman G: Hybrid insulin genes reveal a developmental lineage for pancreatic endocrine cells and imply a relationship with neurons. Cell 53:295-308, 1988
17. Madsen OD, Larsson L-I, Rehfeld JF, Schwartz TW, Lernmark Å, Labrecque AD, Steiner DF: Cloned cell lines from a transplantable islet cell tumor are heterogeneous and express cholecystokinin in addition to islet hormones. J Cell Biol 103:2025-2034, 1986
18. Madsen OD, Jensen J, Blume N, Petersen HV, Lund K, Karlsen C, Andersen FG, Jensen PB, Larsson L-I, Serup P: Pancreatic development and maturation of islet β-cell. Studies of pluripotent islet cultures. Eur J Biochem 242:435-445, 1996
19. Madsen OD, Andersen LC, Michelsen B, Owerbach D, Larsson L-I, Lernmark Å, Steiner DF: Tissue-specific expression of transfected human insulin genes in pluripotent clonal rat lines induced during passage in vivo. Proc Natl Acad Sci U S A 85:6652-6656, 1988
20. Madsen OD, Karlsen C, Nielsen E, Lund K, Kofod H, Welinder B, Rehfeld JF, Larsson L-I, Steiner DF, Holst JJ, Michelsen BK: The dissociation of a tumor-induced weight loss from hypoglycemia in a transplantable pluripotent rat islet tumor result in the segregation of stable α- and β-cell tumor phenotypes. Endocrinology 133:2022-2030, 1993
21. Serup P, Jensen J, Andersen FG, Jørgensen MC, Blume N, Holst JJ, Madsen OD: Induction of insulin and islet amyloid polypeptide production in pancreatic islet glucagonoma cells by insulin promoter factor 1. Proc Natl Acad Sci U S A 93:9015-9020, 1996
22. Serup P, Petersen HV, Pedersen EE, Edlund H, Leonard J, Petersen JS, Larsson L-I, Madsen OD: The homeodomain protein IPF-1/STF-1 is expressed in a subset of islet cells and promotes rat insulin 1 gene expression dependent on an intact E1 helix-loop-helix factor binding site. Biochem J 310:997-1003, 1995
23. Blume N, Skouv J, Larsson L-I, Holst JJ, Madsen OD: Potent inhibitory effects of transplantable rat glucagonomas and insulinomas on the respective endogenous islet cells are associated with pancreatic apoptosis. J Clin Invest 96:2227-2235, 1995
24. Jensen J, Serup P, Karlsen C, Nielsen TF, Madsen OD: mRNA profiling of rat islet tumors reveals Nkx 6.1 as a β-cell-specific homeodomain transcription factor. J Biol Chem 271:18749-18758, 1996
25. Madsen OD, Jensen J, Petersen HV, Pedersen EE, Øster A, Andersen FG, Jørgensen MC, Jensen PB, Larsson L-I, Serup P: Transcription factors contributing to the pancreatic β-cell phenotype. Horm Metab Res 29:265-270, 1997
26. Stoffers DA, Thomas MK, Habener JF: Homeodomain protein IDX-1. A master regulator of pancreas development and insulin gene expression. Trends Endocrinol Metab 8:145-151, 1997
27. Kekow J, Ulrichs K, Müller-Ruchholtz W, Gross WL: Measurement of rat insulin. Enzyme-linked immunosorbent assay with increased sensitivity, high accuracy, and greater practicability than established radio-immunoassay. Diabetes 37:321-326, 1988
28. Heding LG: Determination of total serum insulin (IRI) in insulin-treated diabetic patients. Diabetologia 8:260-266, 1972
29. Dengler WA, Schulte J, Berger DP, Mertelsmann R, Fiebig HH: Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anti-Cancer Drugs 6:522-532, 1995
30. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Methods 65:55-63, 1983
31. Tiedge M, Lortz S, Munday R, Lenzen S: Complementary action of antioxidant enzymes in the protection of bioengineered insulin-producing RINm5F cells against the toxicity of reactive oxygen species. Diabetes 47:1578-1585, 1998
32. Tiedge M, Lortz S, Munday R, Lenzen S: Protection against the co-operative toxicity of nitric oxide and free radicals by overexpression of antioxidant enzymes in bioengineered insulin-producing RINm5F cells. Diabetologia 42:849-855, 1999
33. 15N] nitrate in biological fluids. Anal Biochem 126:131-138, 1982
34. Corbett JA, McDaniel ml: Intraislet release of interleukin 1 inhibits β cell function by inducing β-cell expression of inducible nitric oxide synthase. J Exp Med 181:559-568, 1995
35. Reddy S, Kaill S, Poole CA, Ross J: Inducible nitric oxide synthase in pancreatic islets of the non-obese diabetic mouse: a light and confocal microscopical study of its ontogeny, co-localization and up-regulation following cytokine administration. Histochem J 29:53-64, 1997
36. Offield MF, Jetton TL, Labosky PA, Ray M, Stein RW, Magnuson MA, Hogan BLM, Wright CVE: PDX-1 is required for pancreatic outgrowth and differentiation of the rostral duodenum. Development 122:983-995, 1996
37. Waeber G, Thompson N, Nicod P, Bonny C: Transcriptional activation of the GLUT-2 gene by the IPF-1/STF-1/IDX-1 homeobox factor. Mol Endocrinol 10:1327-1334, 1996
38. Malaisse WJ, Malaisse-Lagae F, Sener A, Pipeleers DG: Determinants of the selective toxicity of alloxan to the pancreatic B cell. Proc Natl Acad Sci U S A 79:927-830, 1982
39. Asayama K, Kooy N, Burr I: Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. J Lab Clin Med 107:459-464, 1986
40. Welsh N, Margulis B, Borg LAH, Wiklund HJ, Saldeen J, Flodström M, Mello MA, Andersson A, Pipeleers DG, Hellerström C, Eizirik DL: Differences in the expression of heat-shock proteins and antioxidant enzymes between human and rodent pancreatic islets: implications for the pathogenesis of insulin-dependent diabetes-mellitus. Mol Med 1:806-820, 1995
41. Bellmann K, Jaattela M, Wissing D, Burkart V, Kolb H: Heat shock protein hsp70 overexpression confers resistance against nitric oxide. FEBS Lett 391:185-188, 1996
42. Tiedge M, Lortz S, Drinkgern J, Lenzen S: Relation between antioxidant enzyme gene-expression and antioxidative defense status of insulin-producing cells. Diabetes 46:1733-1742, 1997
43. Hohmeier H-E, Thigpen A, Tran VV, Davis R, Newgard CB: Stable expression of manganese superoxide dismutase (MnSOD) in insulinoma cells prevents IL-1β-induced cytotoxicity and reduces nitric oxide production. J Clin Invest 101:1811-1820, 1998
44. Grankvist K, Marklund SL, Taljedal IB: CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. Biochem J 199:393-398, 1981
45. Lenzen S, Drinkgern J, Tiedge M: Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20:463-466, 1996
46. Hoorens A, Pipeleers D: Nicotinamide protects human beta-cells against chemically-induced necrosis, but not against cytokine-induced apoptosis. Diabetologia 42:55-59, 1999
47. Suarez-Pinzon WL, Strynadka K, Schulz R, Rabinovitch A: Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. Endocrinology 134:1006-1010, 1994
48. Yamada K, Takane-Gyotoku N, Yuan X, Ichikawa F, Inada C, Nonaka K: Mouse islet cell lysis mediated by interleukin-1-induced Fas. Diabetologia 39:1306-1312, 1996
49. Chervonsky AV, Wang Y, Wong FS, Visintin I, Flavell RA, Janeway CA, Matis LA: The role of Fas in autoimmune diabetes. Cell 89:17-24, 1997
50. Karlsen AE, Pavlovic D, Nielsen K, Jensen J, Andersen HU, Pociot F, Mandrup-Poulsen T, Eizirik D, Nerup J: Cytokine induced nitric oxide and interleukin-1 converting enzyme may represent different pathways of cytokine induced β-cell destruction (Abstract). Diabetologia 41:A56, 1998
51. Ingelsson E, Saldeen J, Welsh N: Islet expression of perform, Fas/Apo-1 and interleukin-1 converting enzyme (ICE) in non-obese diabetic (NOD) mice. Immunol Lett 63:125-129, 1998
52. Helqvist S, Polla BS, Johannesen J, Nerup J: Heat shock protein induction in rat pancreatic islets by recombinant human interleukin 1β. Diabetologia 34:150-156, 1991
53. Strandell E, Buschard K, Saldeen J, Welsh N: Interleukin-1β induces the expression of HSP70, heme oxygenase and Mn-SOD in FACS-purified rat islet β-cells, but not in α-cells. Immunol Lett 48:145-148, 1995
54. Andersen HU, Mose Larsen P, Fey SJ, Karlsen AE, Mandrup-Poulsen T, Nerup J: Two-dimensional gel electrophoresis of rat islet proteins. Interleukin-1β-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide. Diabetes 44:400-407, 1995
55. Andersen H, Fey S, Mose Larsen P, Nawrocki A, Hejnaes KR, Mandrup-Poulsen T, Nerup J: Interleukin-1β induced changes in the protein expression of rat islets: a computerized database. Electrophoresis 18:2091-2103, 1997
56. Mandrup-Poulsen T, Helquist S, Mølvig J, Wogensen L, Nerup J: Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus. Autoimmunity 4:191-218, 1989
57. Wang Z, Gleichmann H: GLUT-2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice. Diabetes 47:50-56, 1998